Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

NCT02192450 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

149

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Nocturnal Hypoglycemia
Recurrent Severe Hypoglycaemia

Interventions

DRUG: Insulin aspart/glargine
DRUG: Insulin aspart/degludec

Sponsor

Nordsjaellands Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]